Paper Details 
Original Abstract of the Article :
Enteric-coated aspirin has been developed in order to decrease the risk of gastrointestinal side effects. When reviewing the existing literature on the effects of the coating on the incidence of gastrointestinal side effects we find that enteric-coated aspirin causes significantly less minor gastroi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/25096559

データ提供:米国国立医学図書館(NLM)

Enteric-Coated Aspirin: A Reassessment of Gastrointestinal Side Effects

This study examines the effectiveness of enteric-coated aspirin in reducing gastrointestinal side effects compared to plain aspirin. The researchers reviewed existing literature on the topic, comparing the incidence of gastrointestinal lesions, dyspepsia, and gastrointestinal bleeding. They found that while enteric-coated aspirin reduced minor gastrointestinal lesions, it did not appear to significantly decrease the incidence of dyspepsia or clinically relevant gastrointestinal bleeding.

Debunking the Myth: Enteric-Coated Aspirin and Gastrointestinal Protection

This study challenges the common belief that enteric-coated aspirin offers superior protection against gastrointestinal side effects. The researchers' findings suggest that while enteric-coating may reduce minor lesions, it does not necessarily prevent more clinically relevant gastrointestinal complications. This information is crucial for understanding the potential benefits and limitations of enteric-coated aspirin for patients at risk of gastrointestinal complications.

Implications for Aspirin Use and Patient Safety

The study's findings provide valuable insights for clinicians and patients regarding the use of enteric-coated aspirin. The researchers' findings emphasize the need for careful consideration of individual risk factors and potential complications when prescribing aspirin, regardless of its coating. Further research is warranted to clarify the long-term effects of enteric-coating and its true impact on gastrointestinal health.

Dr. Camel's Conclusion

This study reminds us that even in the desert of pharmaceutical innovation, some myths persist. The research reveals that enteric-coated aspirin, while seemingly offering protection, may not be the complete solution for gastrointestinal concerns. It's important to approach drug choices with a discerning eye, considering the nuanced realities of their effects.

Date :
  1. Date Completed 2017-12-15
  2. Date Revised 2017-12-15
Further Info :

Pubmed ID

25096559

DOI: Digital Object Identifier

V09130544

Related Literature

SNS
PICO Info
in preparation
Languages

Danish

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.